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Streptococcus pneumoniae infections result in a range of human diseases and are
responsible for almost one million deaths annually. Pneumococcal disease is mediated
in part through surface structures and an anti-phagocytic capsule. Recent studies have
shown that nonencapsulated S. pneumoniae (NESp) make up a significant portion
of the pneumococcal population and are able to cause disease. NESp lack some
common surface proteins expressed by encapsulated pneumococci, but express surface
proteins unique to NESp. A chinchilla model of otitis media (OM) was used to determine
the effect various pneumococcal mutations have on pathogenesis in both NESp and
encapsulated pneumococci. Epithelial cell adhesion and invasion assays were used
to examine the effects in relation to deletion of intrinsic genes or expression of novel
genes. A mouse model of colonization was also utilized for comparison of various
pneumococcal mutants. It was determined that pneumococcal surface protein K (PspK)
and pneumolysin (Ply) affect NESp middle ear pathogenesis, but only PspK affected
epithelial cell adhesion. Experiments in an OM model were done with encapsulated
strains testing the importance of native virulence factors and treatment of OM. First,
a triple deletion of the common virulence factors PspA, PspC, and Ply, (1PAC), from
an encapsulated background abolished virulence in an OM model while a PspC mutant
had detectable, but reduced amounts of recoverable bacteria compared to wildtype.
Next, treatment of OM was effective when starting antibiotic treatment within 24 h with
resolution by 48 h post-treatment. Expression of NESp-specific virulence factor PspK in
an encapsulated strain has not been previously studied, and we showed significantly
increased adhesion and invasion of human epithelial cells by pneumococci. Murine
colonization was not significantly increased when an encapsulated strain expressed
PspK, but colonization was increased when a capsule mutant expressed PspK. The
ability of PspK expression to increase colonization in a capsule mutant despite no
increase in adhesion can be attributed to other functions of PspK, such as sIgA binding or
immune modulation. OM is a substantial economic burden, thus a better understanding
of both encapsulated pneumococcal pathogenesis and the emerging pathogen NESp is
necessary for effective prevention and treatment.
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INTRODUCTION
The pathogenesis of Streptococcus pneumoniae (the
pneumococcus) is varied and complex due in part to surface
structures (Gillespie and Balakrishnan, 2000; Hammerschmidt,
2006; Thornton et al., 2010). Pneumococcal diseases account
for ∼1 million childhood deaths annually worldwide (O’Brien
et al., 2009). However, introduction of the pneumococcal
conjugate vaccine (PCV) has led to a dramatic decline in
invasive pneumococcal disease (IPD) (Fitzwater et al., 2012).
The currently available pneumococcal vaccines target specific
pneumococcal polysaccharide serotypes, 23 in Pneumovax
(Pneumovax R© 23; PPSV23; Merck, Whitehouse Station,
NJ, USA), and 13 in Prevnar [Prevnar 13 R©; PCV13; Pfizer
(formerly Wyeth Pharmaceuticals), New York, NY, USA].
Despite extensive use of the PCV in certain parts of the
world, noninvasive pneumococcal infections are still prevalent
(Weinberger et al., 2011). Noninvasive pneumococcal infections
include nonbacteremic pneumonia, conjunctivitis, otitis media
(OM), and sinusitis. The pneumococcus is a common etiological
agent of OM. In the United States, OM is responsible for most
pediatrician visits (McCaig and Hughes, 1995; Gonzales et al.,
2001; Lieberthal et al., 2013).
The major pneumococcal virulence factor and target of the
PCV is the pneumococcal polysaccharide capsule. There are at
least 97 antigenically distinct capsule types (serotypes), as well as
pneumococci that do not express any capsule (Geno et al., 2015).
Encapsulated strains are dependent on the presence of capsule for
all stages of the life cycle, from colonization to virulence, while
nonencapsulated S. pneumoniae (NESp) do not require a capsule
(Kadioglu et al., 2008). Pneumococcal surface proteins are
required for colonization and mediate virulence independent of
the capsular status. Pneumococcal surface proteins are classified
by means of surface attachment and include choline binding
proteins (CBPs), LPxTG binding, lipoproteins, and nonclassical
surface proteins (Bergmann and Hammerschmidt, 2006).
The surface of NESp and encapsulated pneumococci vary
greatly, not only because of the presence or absence of capsule,
but also based on the various surface proteins expressed.
Regardless of what surface proteins are expressed in either
NESp or encapsulated pneumococci, they are essential for
colonization and pathogenesis (Valentino et al., 2014). The
surface composition between different encapsulated strains also
varies, usually as a result in variations of what genes are encoded
and expressed, along with different protein isoforms. For
instance, the encapsulated pneumococcal CBPs PspA and PspC
have multiple variants and have been shown to be important
for virulence in both invasive and noninvasive infections
(Ogunniyi et al., 2007a). It is important to understand the
alterations in virulence profiles as a consequence of differential
surface protein expression in order to better understand which
strains may be more pathogenic. Furthermore, genetic exchange
between pneumococci occurs rapidly and can alter the virulence
potential of a strain. Past studies examining alterations in surface
proteins have shown that during OM, deletion of PspC reduced
virulence while loss of PspA completely eliminated disease in
a serotype 2 background (Schachern et al., 2014). NESp lack
PspA and PspC but some express the LPxTG binding protein
PspK, which has been shown to increase NESp colonization
and virulence during OM (Park et al., 2012; Keller et al.,
2013, 2014, 2015). We have previously demonstrated adherence
to epithelial cells is an important function of NESp surface
proteins, and increased adhesion of NESp correlated to increased
bacterial burden during OM (Keller et al., 2013, 2014). Another
important virulence factor that all known encapsulated and
nonencapsulated pneumococci possess is pneumolysin (Ply).
It has been shown that Ply has a significant function during
infection (Mitchell and Mitchell, 2010). The role of Ply in NESp
virulence during OM has not been previously established.
Pneumococci are known to exchange genetic material that
has resulted in a high frequency of recombination within the
cps locus, potentially as a consequence of selective pressure
from the use of the PCV (Croucher et al., 2011). Genetic
exchange at the cps locus between encapsulated pneumococci
and NESp may allow encapsulated strains to persist transiently
as a nonencapsulated variant despite vaccination. High rates of
chromosomal recombination are also focused around regions
harboring genes for antibiotic resistance (Croucher et al., 2011).
Antibiotic resistance is commonly observed in pneumococcal
strains, and NESp often harbor multiple drug resistances
(Sulikowska et al., 2004; Chewapreecha et al., 2014; Keller
et al., 2016). Due to rapid transfer of resistance genes
between pneumococcal strains, prompt, and targeted treatment is
necessary for pneumococcal infections. Timely treatment allows
for faster resolution and may limit dissemination into other sites.
The current study demonstrates that the absence of Ply
reduces the ability of NESp to cause OM. Also, epithelial
cell adherence is an important function of OM virulence, but
does not directly lead to pathogenesis of encapsulated strains.
Additionally, we demonstrate that expression of PspK in capsule
mutants partially compensates for the loss of capsule during
colonization, thus affording pneumococci a way to circumvent
increased use of capsule targeting vaccines.
METHODS
Bacterial Strains
Table 1 contains bacterial strains, relevant mutations, and
selective markers used in the current study. All pneumococcal
strains were grown at 37◦C in 5% CO2 in Todd-Hewitt medium
with 0.5% yeast extract (THY), or on sheep blood agar (BA) with
appropriate antibiotic selection as indicated in Table 1. Genomic
and plasmid DNA was obtained using manufacturers protocols
with a DNeasy blood and tissue kit (Qiagen) or a plasmid minikit
(Qiagen), respectively. Plasmids were maintained in Escherichia
coli strain DH5α and grown in Luria Bertani broth (LB) with
appropriate antibiotic selection.
Genetic Manipulations
Gene deletions were made through allelic replacement.
Pneumococcal transformations were performed in competence
media (THY, 0.2% fresh bovine serum albumin, 0.01% CaCl2,
and 0.1% glucose). Bacteria were grown in competence media to
approximately OD600 0.2, diluted 1:20 in competence media, and
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TABLE 1 | Bacterial strains used in this study.
Strain Parent strain Serotype Mutation Markera References
D39 2 Avery et al., 1944
1PAC D39 2 Ply/PspA/PspC Tmp-Tet-Erm Quin et al., 2007
Deletion (10 µg/ml-5 µg/ml-0.3 µg/ml)
R36A D39 2 Capsule Mutation Taylor, 1949
LEK20 D39 2 PspK Addition Kan (500 µg/ml) This study
AM1000 D39 2 Capsule Mutation Magee and Yother, 2001
LEK16 D39 2 Capsule Deletion/PspK Addition Kan (500 µg/ml) This study
MNZ67 NESp Park et al., 2012
LEK05 MNZ67 NESp PspK Deletion Spec (300 µg/ml) This study
LEK07 MNZ67 NESp Ply Deletion Tmp (10 µg/ml) This study
LEK11 MNZ67 NESp PspK/Ply Deletion Spec-Tmp (300 µg/ml-10 µg/ml) This study
EF3030 19F Andersson et al., 1983
LEK10 EF3030 19F PspC Deletion Erm (0.3 µg/ml) This study
LEK12 EF3030 19F Capsule Deletion Spec (300 µg/ml) This study
LEK14 EF3030 19F PspK Addition Kan (500 µg/ml) This study
LEK15 EF3030 19F Capsule Deletion/PspK Addition Spec-Kan (300 µg/ml-500 µg/ml) This study
aTmp-trimethoprim; Tet, Tetracycline; Erm, Erythromycin; Kan, Kanamycin; Spec, Spectinomycin.
stimulated with 2 µg/ml of competence-stimulating peptide 1
(CSP-1) for 12 min before the addition of∼1 µg of DNA (Yother
et al., 1986). Pneumococci were incubated for 4 h at 37◦C before
plating on BA containing appropriate antibiotic selection.
DNA for pspK deletion in MNZ67 and cps deletion in EF3030
was obtained through polymerase chain reaction (PCR) of
genomic DNA isolated from MNZ1131 (Park et al., 2012) with
primers DexBF (5′-GACTATCTAGCCAAGCTAGG-3′) and
AliAR (5′- CCCTGTACGAGATGTAGTTG -3′). DNA for ply
deletion was isolated from 1Ply2 (Thornton and McDaniel,
2005) using primers UpstreamPlyF (5′-CTAGCCTTGACAACT
AGCCAATC-3′) and DownstreamPlyR (5′-TGCAAATAGAAA
GTTTCAGCC-3′). Expression of PspK was achieved through
ectopic expression using plasmid pABG5. The pspK gene was
isolated from genomic MNZ67 DNA using primers pABG5
PspKF (5′-GCGGAATTCATGAATAATAAGAATATCATC
CCGATGAG-3′) and pABG5 PspKR (5′-GCGCTGCAGCTA
ATTTTTATGTTTAACAAATGGAAGA-3′). Primers contain
restriction sites EcoRI and PstI, respectively, indicated by bolded
and underlined section of primer. Plasmid pABG5 and pspK
amplicon was digested with EcoRI (NEB) and PstI (NEB), ligated
with T4 DNA ligase (Thermo Scientific) and transformed into
DH5α making pABG5::pspK. Plasmid verified by sequencing and
PspK levels in wildtype MNZ67 and PspK expression mutants
were equivalent as determined by flow cytometry and Western
blot analysis.
Adhesion and Invasion Assays
Adhesion and invasion assays were performed as previously
described (Keller et al., 2013). In brief, 24 well-plates were
seeded to ∼90% confluency with human pharyngeal cell line
Detroit 562 or lung cell line A549. Epithelial cells were incubated
with 1 × 107 CFU/ml of bacteria suspended in EMEM for
30 min then washed two times with 1X PBS to remove
unbound pneumococci. Epithelial cells were trypsinized (100
µl 0.25% Trypsin-EDTA) and plated on BA for enumeration.
Invasion assays were performed as above, but epithelial cells
were incubated with bacteria for 2 h before being washed two
times with 1X PBS. Washed cells were further incubated for 1
hr with EMEM containing 10 µg/ml penicillin and 200 µg/ml
streptomycin to kill extracellular bacteria. Epithelial cells were
washed and trypsinized as above before enumeration on BA.
Experimental OM
Experimental OM was performed as previously described (Keller
et al., 2014). In brief, young adult chinchillas (Chinchilla lanigera,
body weight 400–500 g) from Ryerson Chinchilla Ranch were
allowed to acclimate for at least 7 days. Otoscopic examination
was used to examine the tympanic membrane of all animals
before infection. Chinchillas with no visible pathology received
100 µl transbullar injections containing 1 × 107 NESp or 1 ×
102 encapsulated pneumococci in 1X PBS containing 0.04%
gelatin. Differences in inoculum amounts between NESp and
encapsulated pneumococci were calculated in accordance to
previous studies that displayed encapsulated pneumococci to be
highly invasive causing sepsis and death very rapidly at high
inoculums in this model (Forbes et al., 2008). Chinchillas were
injected with 1 × 104 of the D39 mutant 1PAC due to a
known reduction of virulence in other animal models (Ogunniyi
et al., 2007b). Infections with encapsulated pneumococci were
only performed out to 3 days due to significant pathology
of these strains. Animals were monitored daily for clinical
symptoms (listing, loss of appetite, and response to stimulus or
noise) and tympanic membrane was visualized for inflammation
immediately following euthanasia with a Karl Storz Vetcam XL
692800 20 with an otoscopic attachment. Samples were collected
and visible tympanic inflammation and biofilm formation were
scored. Tympanic inflammation was scored through otoscopic
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examination as follows: 0 = none, 1 = inflammation, 2 =
effusion, and 3 = tympanic rupture. The tympanic membrane
of an uninfected chinchilla is an opalescence off-white color
with inflammation defined as visible rubor or yellowing of the
membrane. Effusion of the middle ear is indicated by physical
presence of fluid upon sample processing or yellowing of the
tympanic membrane with visible pockets of air behind the
membrane. Tympanic rupture is indicated by a breach of the
tympanic membrane with possible drainage. Biofilm formation
was visibly scored as follows: 0 = none, 1 = surface formation,
2 = traverses bulla, and 3 = traverses bulla with thickening. For
treatment experiments, ampicillin (100 mg/kg) was administered
intramuscularly every 12 h starting at the indicated time points.
Individual data points in OM studies represent each bulla per
animal (2 total), with at least two biological replicates examining
1–2 chinchillas per replicate. All animal studies were performed
in accordance with protocols approved by the University of
Mississippi Medical Center Institutional Animal Care and Use
Committee.
Murine Colonization
Mouse studies were performed as previously described (Keller
et al., 2013). In brief, 6–8 week old C57/BL6 mice were lightly
anesthetized with isoflurance and intranasally (IN) challenged
with 10 µl 1X PBS containing ∼1 × 107 bacteria. Five days
post-challenge, mice were euthanized, nasopharyngeal lavage,
and tissue samples as well as bullae were collected, and bacteria
were enumerated on BA containing 5µg/ml gentamicin. Samples
were collected through retrograde lavage of 200 µl sterile saline
solution starting from exposed trachea and samples collected
from the nares. Mice were decapitated and physically denuded
of fur followed by transverse sectioning of skull posterior
of orbital sockets. Anterior section of the skull was bisected
down sagittal plane and nasopharyngeal tissue collected with
forceps and homogenized in 200 µl 1X PBS before enumeration.
Colonizing bacteria are a combination of bacterial counts
from lavage and nasopharyngeal tissue from the same mouse.
Pneumococcal ascension to the middle ear was assessed by
bacterial enumeration of bullae collected from the IN challenged
mice. The posterior section of the skull was bisected down the
sagittal plane and brain removed from both sections. Bullae
were located slightly posterior and caudally of external ear canal,
removed with forceps, and homogenized in 200µl 1X PBS before
enumeration on BA containing 5 µg/ml gentamicin.
Statistical Analysis
Results from adhesion assays were determined by Student’s t-
test with the InStat program (GraphPad Software). For OM and
colonization, the numbers of CFU in the different experimental
groups were compared using the Mann-Whitney test with the
InStat program. Significant results are indicated by P values of
<0.05.
RESULTS
We have previously demonstrated that deletion of PspK from
NESp MNZ11, a sequence type (ST) 6151, reduced pathogenesis
in anOMmodel and significantly reduced epithelial cell adhesion
(Keller et al., 2014). Deletion of PspK from NESp MNZ67
(ST1464) also significantly reduced bacterial burden during OM
in a chinchilla model, p< 0.0001 (Figure 1A). Inflammation and
biofilm formation were significantly reduced when comparing
PspK deletion mutant (LEK05) to wildtype (MNZ67), p = 0.028
and p = 0.0027, respectively (Table 2). Next, the significance
of Ply in NESp OM pathogenesis was determined because
pneumolysin has been associated with increased inflammation
(Hirst et al., 2004). We observed a significant reduction in
recovered bacteria from the middle ear (Figure 1A). Also, a
significant reduction in biofilm formation was observed when
ply was deleted (Table 2). Next a double mutant lacking both
PspK and Ply was tested for virulence during OM. Surprisingly,
there was no significant difference in the number of bacteria
recovered from the chinchilla middle ear in comparison to
wildtype MNZ67, p> 0.05. (Figure 1A).
FIGURE 1 | Deletion of pneumococcal virulence factors significantly reduces bacterial burden during experimental OM. (A) Single gene deletion of pspK
(LEK05; p < 0.0001) or ply (LEK07; p = 0.0016) and double gene deletions of pspK and ply (LEK11; p = 0.1243) had significant reductions in recovered bacteria
compared to wildtype NESp MNZ67. (B) Serotype 2 pneumococcal strain D39 had high levels of bacteria recovered from the middle ear of chinchillas, but no bacteria
were recovered when chinchillas were challenged with a D39 triple gene deletion mutant 1PAC or acapsulalar mutant R36A (p < 0.0001). Data represents at least
two independent experiments of four bullae per experiment.
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Previous studies have shown the importance of PspA and
PspC for encapsulated pneumococci (serotype 2) during OM
(Schachern et al., 2014). We have shown the importance of
Ply for NESp OM virulence in contrast to past work in
encapsulated pneumococci (serotype 3) (Sato et al., 1996). A
combination of PspA, PspC, and Ply deletion have not been
tested in encapsulated strains. We found that deleting all three
proteins from serotype 2 strain D39 (1PAC) and deletion of
capsule (R36A) completely attenuated virulence in comparison
to wildtype, p < 0.0001 (Figure 1B). A corresponding reduction
in inflammation and biofilm formation was observed when
comparing triple mutant 1PAC and capsule mutant R36A to
wildtype D39 p< 0.0001 (Table 2).
As previously reported, increased adhesion of NESp to
epithelial cells correlated with increased bacterial recovery from
the middle ear of chinchillas (Keller et al., 2014). Due to
reduced bacterial recovery of Ply deletion mutants, we wanted
to determine if Ply impacted epithelial adhesion. Although we
observed a reduction in pneumococci recovered during OM,
TABLE 2 | Inflammation and biofilm scores of infected chinchillas.
Strain Inflammation
score
Biofilm
formation
Inflammation
P-value
Biofilm
P-value
MNZ67 1.00 ± 0.41 2.00 ± 0.41
LEK05 0.00 ± 0.00 0.25 ± 0.25 0.0286 0.0002
LEK07 0.50 ± 0.29 0.50 ± 0.29 0.33 0.0015
LEK11 1.375 ± 0.26 1.00 ± 0.27 0.45 0.061
D39 1.50 ± 0.29 2.00 ± 0.00
1PAC 0.00 ± 0.00 0.00 ± 0.00 0.0021 0.0001
R36A 0.50 ± 0.25 0.60 ± 0.37 0.04 0.0091
EF3030 2.00 ± 0.00 1.75 ± 0.25
LEK10 1.50 ± 0.29 2.00 ± 0.00 0.1354 0.4816
Scores are average with standard error of the mean with significant p-values indicated in
bold. P-value is for mutant vs. parent strain.
Figure 2A shows deletion of ply did not reduce epithelial cell
adhesion to pharyngeal cell line Detroit 562 (p > 0.05). This
indicated that another virulence mechanism, such as biofilm
formation, may be responsible for the decrease in recovered
bacteria. As expected deletion of PspK from wildtype strain
MNZ67 did reduce epithelial adhesion (p < 0.0001). Deletion
of capsule has been shown to increase epithelial cell adhesion
of encapsulated strains, which we verified here (Figure 2B).
Increased epithelial cell adherence of NESp has led to increased
bacterial recovery during experimental OM, but we did not
observe that correlation when capsule genes were deleted from
encapsulated strains despite increased epithelial cell adherence.
We have shown that D39 (serotype 2) can infect chinchillas
and specific virulence factors play a role in pathogenesis.
Unfortunately D39 resulted in high virulence in the chinchilla
OM model with as few as 10 CFU causing death in some
chinchillas limiting its usefulness due to ethical reasons (data
not shown). We wanted to determine if other serotypes were
as virulent as D39 during an OM infection, so we investigated
encapsulated strain EF3030 (19F, known causative serotype
of OM) for our infection model (Joloba et al., 2001). High
bacterial loads of EF3030 were recovered from the middle ear of
chinchillas during experimental OM (Figure 3) with a portion
of infected chinchillas becoming septic. However, chinchillas
infected with EF3030 had better clinical outcomes than D39
infected animals (data not shown). No difference between
inflammation or biofilm formation was observed between D39
and EF3030, p > 0.05 (Table 2). In an effort to reduce
invasiveness of encapsulated EF3030, PspC was deleted. Deletion
of PspC from EF3030 (LEK10) reduced bacterial burden, p =
0.0026, but did not prevent invasive infections in chinchillas
(Figure 3).
We next wanted to determine if treatment of an OM infection
prone to systemic invasion was treatable with commonly
prescribed antibiotics, and if the time of treatment aided in
outcome. Amoxicillin is a commonly prescribed antibiotic for the
treatment of OM (Lieberthal et al., 2013). The use of ampicillin
FIGURE 2 | Adhesion of pneumococci to human pharyngeal epithelial cell line Detroit 562 is affected by specific gene deletions. (A) Deletion of pspK
from wildtype NESp MNZ67 significantly reduced bacterial adhesion to epithelial cells, but no effect was seen with a ply gene deletion. Deletion of pspK and ply from
MNZ67 (LEK11) significantly reduced epithelial cell adhesion compared to wildtype MNZ67 (p < 0.0001). (B) Pneumococcal epithelial cell adhesion was significantly
increased in both D39 mutants, 1PAC and R36A (p < 0.0001). Data represents three independent experiments in triplicate.
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FIGURE 3 | Encapsulated strain EF3030 (serotype 19F) middle ear
pathogenesis in chinchillas are not mediated by PspC. There is a
significant decrease in the amount of bacteria recovered from the middle ear of
chinchillas when comparing wildtype EF3030 to pspC gene deletion (LEK10).
Data represents samples from four bullae.
for our study avoids excess stress upon the animals by reducing
the handling necessary to gavage treatment into an infected
chinchilla. We found that treatment starting within 24 h post-
infection was able to completely clear EF3030 infection, p <
0.0001 (Figure 4A). Treatment starting 48 h after infection was
also able to reduce bacterial burden, but only by two logs
compared to no treatment, p < 0.005 (Figure 4A). EF3030 with
no treatment had increased inflammation (Figure 4C) compared
to treatment starting at 24 h post-infection (Figure 4B) or 48 h
post-infection (Figure 4D).
We have shown that pneumolysin and surface proteins impact
pneumococcal virulence and rapid treatment is necessary to
efficiently clear infections and limit systemic dissemination.
Genetic exchange between pneumococci occurs regardless of
capsule status, but the effect of a NESp-specific surface protein
expressed in an encapsulated strain has never been determined.
Past studies have utilized D39 acapsular derivative R36A for
PspK expression in an encapsulated background (Keller et al.,
2013, 2014), but R36A has been lab adapted for decades and
may not represent a capsule exchange that occurs naturally.
Here, we use a PspK expressing plasmid to determine the effects
of PspK expression on encapsulated pneumococcal adherence
and colonization with and without the presence of capsule. As
shown in Figures 5A,B, expression of PspK in encapsulated
strains EF3030 and D39 increased their ability to adhere to lung
epithelial cell line A549, p < 0.0001 and p = 0.032 respectively.
While this is independent of the two serotypes tested, EF3030
(serotype 19F) had a significantly greater increase in lung
epithelial cell adhesion than D39 (serotype 2). The deletion of
capsule increased epithelial cell adhesion with or without the
presence of PspK. Surprisingly, expression of PspK in acapsular
mutants did not significantly increase epithelial cell adhesion
when the capsule was absent. This is in contrast to past work
using the D39 capsule mutant R36A (Keller et al., 2013). There
was a concurrent increase in epithelial cell invasion in all samples
in which epithelial cell adhesion was increased (Figures 5C,D).
We next wanted to determine if these effects in vitro were
also observed in a mouse model. Since increased adherence
may correlate to enhanced virulence of encapsulated strains,
the chinchilla OM virulence model was avoided due to ethical
consideration of the animals. EF3030 was chosen for this model
because it is a known colonizer of the mouse nasopharynx
and, unlike D39, does not disseminate into the blood in mice.
As shown in Figure 6A, there was no difference in the ability
of EF3030 to colonize when PspK was present or absent. In
contrast, when the capsule is removed from EF3030 and PspK
is expressed, there were significantly more bacteria recovered
from the mouse nasopharynx (p = 0.0082), but not equivalent
to wildtype EF3030 levels. The amount of bacteria that ascended
through the mouse Eustachian tube into the middle ear was
also quantified (Figure 6B). Expression of PspK in EF3030 or in
EF3030 capsule mutant LEK12 did not significantly increase the
number of bacteria collected from the middle ear.
DISCUSSION
PspK plays an important role in NESp pathogenesis along with
pneumolysin (Ply) (Figure 1). While PspK mediated virulence
is through increased epithelial cell adhesion, Ply virulence
is not (Figure 2A). The expression of PspK in encapsulated
strains increases adhesion in vitro to human epithelial cells
(Figures 5A,B), but does not correlate to increased ability to
colonize the mouse nasopharynx. Colonization by a capsule
mutant of an encapsulated strain is partially rescued by the
expression of PspK, but not to the level of a wildtype encapsulated
strain (Figure 6A). We were also able to show the importance
of surface proteins for OM in encapsulated strains, as well as an
increased efficacy of treatment when the treatment is started early
during infection.
We first described PspK as a virulence protein in the chinchilla
using MNZ11, a ST6151 strain that is genetically related to other
NESp based on sequence type (Keller et al., 2014). The current
study uses a NESp MNZ67, a ST1464 that has been previously
associated with pneumococci of the 19F serotype.We determined
that PspK performs a similar function in NESp regardless of the
genetic background in which it is being expressed, both in terms
of in vitro epithelial cell adhesion and in vivo pathogenesis. The
role of Ply, a known virulence factor found in all encapsulated
and nonencapsulated pneumococci, was also examined in NESp
virulence. We were able to demonstrate a significant decrease
in virulence during OM when Ply was not expressed (Figure 1),
and this is independent of epithelial cell adhesion. Decreased
virulence wasmost notable in the amount of biofilm in themiddle
ear, with the Ply mutant producing significantly less biofilm than
wildtype MNZ67 (Table 2). This is unsurprising due to previous
reports on the importance of Ply for biofilm formation and helps
explain the decrease in recovered bacteria (Shak et al., 2013).
Recent reports of NESp have also identified a second Ply-like
Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 6 May 2016 | Volume 6 | Article 55
Keller et al. Pneumococcal Virulence in Experimental OM
FIGURE 4 | Effect of bacterial burden and clinical symptoms of systemic ampicillin treatment of EF3030 OM model. (A) Untreated animals had high levels
of recovered bacteria and ampicillin treatment significantly reduced bacterial burden. Treatment starting 24 h post-infection cleared all detectable bacteria from the
middle ear and treatment starting 48 h post-infection had a smaller, but significant reduction in recovered bacteria. (B) Tympanic membrane of animal 72 h
post-infection and 48 h after start of treatment. (C) Tympanic membrane of mock treated animal 72 h post-infection. (D) Tympanic membrane of animal 72 h
post-infection and 24 h after start of treatment. Data represents samples from four bullae and representative pictures.
gene (plyB) that is more closely related to cytolysins of other
streptococcal species (Morales et al., 2015). The presence of
this second cytolysin may compensate for the deletion of the
canonical Ply, but this has yet to be tested. This led to the question
of the importance of pneumolysin in encapsulated strains during
experimental OM.
In contrast to this study with a pneumolysin mutant in
NESp, a previous study in encapsulated pneumococci showed
no effect on OM virulence (Sato et al., 1996). It has been
previously reported that the choline binding proteins PspA
and PspC both play a role in pneumococcal pathogenesis,
including middle ear infections (Schachern et al., 2014). We
examined the encapsulated strain D39 and a triple deletion
mutant (1PAC) that lacks PspA, PspC, and Ply because previous
studies showed variable effects of individual mutants, but none
containing all deletions (Schachern et al., 2014). The 1PAC
mutant has been found to be avirulent in other infection models
(Ogunniyi et al., 2007b; Quin et al., 2007), but has not been
previously tested in chinchillas. NESp lack both PspA and
PspC yet are able to cause OM. Additionally, we have shown
here that although virulence is reduced, a NESp Ply mutant
is still able to cause an infection (Figure 1). The surface of
the D39 mutant 1PAC is similar to NESp by lacking these
proteins, but still retains the important capsule virulence factor.
Unlike NESp, 1PAC was unable to cause OM and had no
visible signs of pathology. While 1PAC was inoculated at a
lower CFU/ml than NESp, we have been able to previously
recover NESp from chinchillas infected with as little as 1 ×
104 inoculum but with a reduction in total number of infected
animals (unpublished data). While capsule is important for
encapsulated pneumococcal pathogenesis, it in itself is not
sufficient to cause disease. Surprisingly, 1PAC had increased
adherence in comparison to wildtype D39. While increased
adherence of NESp has been associated with higher rates of
virulence in an OM model, this does not seem to hold for
capsule mutants (Keller et al., 2014). Park et al. (2012) showed
significantly less colonization by AM1000 in a mouse model
compared to D39 despite higher rates of epithelial cell adhesion.
We also examined the encapsulated strain EF3030 (serotype
19F) in a chinchilla model because it is less virulent in a
mouse model and the serotype 2 D39 caused fatal pathology
in several chinchillas within the time course of the study. We
also tested a PspC mutant in the EF3030 background (LEK10)
to reduce the invasive nature of EF3030. Both the wildtype and
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FIGURE 5 | Encapsulated strain EF3030 (serotype 19F) and mutants adherence and invasion to lung epithelial cell line A549. (A) Expression of PspK in
serotype 19F EF3030 (LEK14) significantly increased epithelial cell adhesion when capsule was present (p < 0.0001). Deletion of capsule significantly increased
epithelial cell adhesion (LEK12; p < 0.0001) compared to wildtype EF3030. Expression of PspK in LEK12 (EF30301cps) did not increase adhesion of LEK15
(EF30301cps::PspK+) compared to acapsular EF3030 (LEK12). (B) Expression of PspK in serotype 2 D39 (LEK20) significantly increased epithelial cell adhesion
when capsule was present (p = 0.034). Deletion of capsule significantly increased epithelial cell adhesion (AM1000; p < 0.0001), but expression of PspK in AM1000
(D391cps) did not increase adhesion of LEK16 (D391cps::PspK+). (C) Expression of PspK in serotype 19F EF3030 (LEK14) significantly increased epithelial cell
invasion when capsule was present (p = 0.0024). Deletion of capsule significantly increased epithelial cell invasion (LEK12; p = 0.0149) compared to wildtype
EF3030. Expression of PspK in LEK12 (EF30301cps) did not increase invasion of LEK15 (EF30301cps::PspK+) compared to acapsular EF3030 (LEK12). (D)
Expression of PspK in serotype 2 D39 (LEK20) significantly increased epithelial cell invasion when capsule was present (p = 0.047). Deletion of capsule significantly
increased epithelial cell adhesion (AM1000; p < 0.0001), but expression of PspK in AM1000 (D391cps) did not increase adhesion of LEK16 (D391cps::PspK+). Data
represents three independent experiments in triplicate.
FIGURE 6 | Encapsulated strain EF3030 (serotype 19F) and mutants in a mouse model of colonization. (A) At 5 days post-infection, enumerated bacteria
recovered from the mouse nasopharynx did not significantly increase when encapsulated EF3030 expressed PspK. EF3030 capsule mutant, LEK12, showed
significantly more colonization when PspK was expressed (LEK15; p = 0.0082). (B) Collected bullae from colonized mice showed no significant difference in middle
ear ascension when PspK was expressed independent of capsule status. Mean CFU/mouse indicated by horizontal bar on figure.
the PspC mutant were able to cause OM, but there was no
significant difference between clinical symptoms. However, there
was significantly fewer pneumococci recovered from the middle
ear of chinchillas infected with the PspC mutant (Figure 3). In
both EF3030 and LEK10, we were able to recover bacteria from
the blood of infected chinchillas, and this led to the question of
treatment.
Amoxicillin is a commonly prescribed antibiotic for middle
ear infections, and EF3030 is susceptible to ampicillin and its
derivations. Amoxicillin is an oral antibiotic that is absorbed
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through the stomach and must be ingested for effective
treatment. This entails restraining and gavaging chinchillas for
treatment, inducing high amounts of stress given that treatment
is administered every 12 h. Therefore, an injectable form of
ampicillin was used as a substitute. We found that treatment
administered 24 h after infection was able to completely clear
OM within 48 h of start of treatment. This corresponded to
reduced tympanic inflammation and a better clinical outcome.
We also show that treatment administered 48 h after infection
is still sufficient to reduce the bacterial burden during OM,
even though only 24 h had elapsed since start of treatment
(Figure 4). It was not surprising that ampicillin treatment cleared
the pneumococcal infection, but it was somewhat surprising as
how fast this occurred. This information is important to know
as studies on treatment of NESp in middle ear infections have
not been done, even though these bacteria tend to be highly
drug resistant. Additionally, OM co-infections of pneumococcus
and nontypeable Haemophilus influenzae (NTHi) are common
(Casey and Pichichero, 2004; Dagan et al., 2013). It has been
shown that secreted beta-lactamases from NTHi significantly
improve survival of pneumococci in the middle ear (Weimer
et al., 2011). Elucidating treatment and time to resolution of
infection is necessary to determine the effectiveness of various
antibiotics and to overcome the consequences of co-infections.
An interesting observation during this study was deletion
of PspA, PspC, and Ply abolished D39 virulence even when
capsule was present. Surface proteins are important for virulence,
but NESp that lack common encapsulated surface proteins
cause disease. We wanted to determine the effect of PspK
expression on encapsulated strains and whether the expression
of PspK in a capsule mutant is able to restore virulence. Despite
pspK being located at the cps locus, it may be possible for
an encapsulated variant to express PspK due to pneumococcal
natural transformation and high levels of genetic variability.
It has been observed that aliD, a NESp cps locus protein, is
found in the cps locus of some encapsulated strains (Bentley
et al., 2006; Keller et al., 2016). Ectopic expression of PspK in
an encapsulated background was able to significantly increase
the ability of an encapsulated strain to adhere to both lung
and pharyngeal epithelial cell lines. This seems independent
of capsule as the same effect was observed in a serotype 2
background (D39) and a serotype 19F background (EF3030).
While an increase in adherence was observed in both serotypes,
there was a significantly greater increase in adhesion when
comparing EF3030 to D39 (Figures 5A,B). It is speculated that
the capsule structure may affect the ability of PspK to increase
adherence. This is because the type 2 capsule is composed of 6
repeating sugar subunits in comparison to the type 19F capsule
which contains 3 repeating sugar subunits, which may alter
capsule size and accessibility of PspK to epithelial cells (Bentley
et al., 2006).
We were able to confirm that the deletion of the cps locus
from encapsulated strains significantly increased epithelial cell
adhesion of these mutants (Figures 5A,B). Surprisingly, the
expression of PspK had no significant effect on epithelial cell
adhesion when capsule was not present. This could be explained
by a saturation of the epithelial cells, reducing the ability of
PspK to interact with the epithelial cells. These findings are in
contrast to our past work when expression of PspK in R36A
did show a significant increase in epithelial cell adhesion. The
capsule mutants made for this study were minimally passed,
while the D39 derivative R36A has been passed multiple times
and for several decades. This may have altered the surface of
R36A compared to a recently made capsule mutant. When a
mouse was colonized with these PspK expression strains with or
without capsule, an opposite trend of what would be expected
based on the adhesion data was observed (Figure 6A). The highly
adherent EF3030 expressing PspK (LEK14) had no significant
difference in colonization. Yet when PspK was expressed in a
EF3030 capsule mutant (LEK15), there was significantly more
bacteria recovered from the mouse nasopharynx. This effect
must be independent of epithelial cell adhesion, as a capsule
mutant was adherent with or without PspK expression. We
have previously shown that PspK does bind sIgA and this may
aid in colonization. Also, we have shown that PspK may be
responsible for modulating the host immune response (Keller
et al., 2015). If PspK down regulated innate immune responses,
it would allow the more vulnerable capsule mutant to readily
persist, which was our observation. The effects of PspK on
cytokine expression were mild and may explain why only a
small increase in colonizing bacteria was observed (Keller et al.,
2015).
Taken together this work shows surface structures and Ply
are important for pneumococcal OM in both encapsulated
and nonencapsulated pneumococci. Also, deletion of multiple
virulence factors seems to have a greater impact on virulence than
single gene deletions. While this is not surprising, it emphasizes
the importance for protein-based vaccines to contain multiple
proteins for both broader and more complete protection.
Targeting single proteins may not be sufficient to abolish
virulence or clear an infection. NESp lack several of the proteins
being developed for a protein vaccine, but PspK has been
shown to be a protective immunogen (Keller et al., 2015).
As replacement of capsule can be partially compensated for
by acquisition of PspK, inclusion of PspK in future vaccine
developmentmay be necessary to provide the broadest protection
possible.
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